Status:
COMPLETED
Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe
Lead Sponsor:
European Institute of Oncology
Conditions:
Neuroendocrine Tumors
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Radioguided surgery (RGS) with beta- radioisotopes is a novel approach focused on developing a new probe which, detecting electrons and operating with low background, provides a clearer delineation of...
Detailed Description
Small Intestinal neuroendocrine patients, with a positive Ga-68-DOTATOC PET/CT, will receive a small amount of beta- radiopharmaceutical (Y-90-DOTATOC), and then operated, as clinical indicated. Tiss...
Eligibility Criteria
Inclusion
- SI NET patients, Ga-68-DOTATOC PET/CT positive, proposed for surgery
Exclusion
- negative PET/CT; pregnancy
Key Trial Info
Start Date :
February 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04296149
Start Date
February 16 2017
End Date
December 31 2019
Last Update
March 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chiara Maria Grana
Milan, Italy, 20141